Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $13,620 - $18,222
-23 Reduced 41.82%
32 $24,000
Q3 2023

Nov 15, 2023

SELL
$434.7 - $599.3 $15,214 - $20,975
-35 Reduced 38.89%
55 $29,000
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $27,956 - $32,833
90 New
90 $30,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Studio Investment Management LLC Portfolio

Follow Studio Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Studio Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Studio Investment Management LLC with notifications on news.